{
  "Clinical History Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Steven,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3120, 
        3143
      ]
    }
  ], 
  "Comments Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Steven,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4571, 
        4591
      ]
    }
  ], 
  "Final Diagnosis Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Steven,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3176, 
        3203
      ]
    }
  ], 
  "Laterality (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3216, 
        3220
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3535, 
        3539
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3956, 
        3960
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4372, 
        4376
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4441, 
        4445
      ]
    }
  ], 
  "Macroscopic/Gross Description Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Steven,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        673, 
        702
      ]
    }
  ], 
  "Microscopic Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Steven,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4264, 
        4299
      ]
    }
  ], 
  "Nature of Specimen Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Steven,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4341, 
        4367
      ]
    }
  ], 
  "Negative Findings Phraseology (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3401, 
        3424
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3720, 
        3743
      ]
    }, 
    {
      "__agreement__": "FALSE NEGATIVE", 
      "__annotator__": "Gemma", 
      "__extent": [
        4139, 
        4202
      ]
    }
  ], 
  "Neoplasm Behaviour (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3265, 
        3271
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3584, 
        3590
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4003, 
        4009
      ]
    }
  ], 
  "Organ/Body Structure (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3208, 
        3214
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3527, 
        3533
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3948, 
        3954
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4377, 
        4383
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20171128_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4446, 
        4452
      ]
    }
  ], 
  "Specimen Identifier (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3205, 
        3207
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3524, 
        3526
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3945, 
        3947
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4369, 
        4371
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4438, 
        4440
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4507, 
        4508
      ]
    }
  ], 
  "__text": "MSH|^~\\&|PathSys|Associated Pathologists, LLC d/b/a PathGroup^44D1053014^CLIA|eMARCPlus|TN Cancer Registry|20170919125826||ORU^R01^ORU_R01|201709191258260001|P|2.5.1|TN||||||||VOL_V_40_ORU_R01-CCR1^NAACCR_CP\nOBR|1||17-21-008535^PathSys^44D1053014^CLIA|11529-5^SURGICAL PATH REPORT^LN|||20170824000000|||||||20170824000000|&Breast, Biopsy, not requiring microscopic margins, Breast, Biopsy, not requiring microscopic margins, Breast, Biopsy, not requiring microscopic margins|1497752489^^^^^^M.D.^^CMS^D^^^NPI||||||20170825000000|||F||||||N64.1^Fat necrosis of breast^I10~C50.912^Malignant neoplasm of unspecified site of left female breast^I10|1629211198&&&&&&&&CMS\n\n\n\n\n\n\n\nPath report.gross description\n\n1. Received in formalin labeled \"\" and \"left breast superior anterior margin, long lateral, short superior\" is an irregular fragment of yellow lobulated fatty breast tissue containing orienting sutures (short is superior, long is lateral) and has the following measurements: 4.0 lateral to medial, 2.5 cm superior to inferior, and 1.0 cm anterior to deep. The margins are inked as follows: Superior blue, inferior green, lateral yellow, medial red, anterior orange,and deep is inked black. Serially sectioning lateral to medial reveals a lobulated fatty cut surface. No masses or lesions are otherwise identified. Representative sections are submitted as follows: 1A, lateral and medial margins, 2/1; 1B-1E, remainder of specimen entirely submitted with respective anterior, deep, superior, and inferior margins; 1B, 1/1; 1C, 2/1; 1D, 1/1; 1E, 2/1. 2. Received in formalin labeled \"\" and \"left breast inferior anterior margin, long lateral, short superior\" is an irregular portion of fatty breast tissue containing orienting sutures (short superior, long lateral) and has the following measurements: 3.6 cm medial to lateral, 1.8 cm superior to inferior, and 0.8 cm anterior to deep. The margins are inked as follows: Superior blue, inferior green, lateral yellow, medial red, anterior orange, posterior black. Serially sectioning lateral to medial reveals a lobulated fatty cut surface. No firm areas or masses are grossly identified. The specimen is submitted as follows: 2A, medial and lateral margins, 2/1; 2B-2D, remainder of specimen with respective anterior, deep, superior, and inferior margins; 2B, 3/1; 2C and 2D, 2/1 in each. 3. Received in formalin labeled \"\" and \"medial anterior margin, long lateral, short superior\" is an irregular portion of fatty breast tissue containing orienting sutures (short is superior, long is lateral) and has the following measurements: 2.7 cm medial to lateral, 2.2 cm superior to inferior, 1.0 cm anterior to deep. The margins are inked as follows: Superior blue, inferior green, lateral yellow, medial red, anterior orange, deep black. Serially sectioning lateral to medial reveals a lobulated fatty cut surface. No firm areas or masses are grossly identified. The specimen is submitted as follows: 3A, lateral and medial margins, 2/1; 3B-3D, remainder of specimen with respective anterior, deep, superior, and inferior margins; 3B and 3C, 1/1 in each; 3D, 2/1. (MD3)\n\n\nPath report.relevant Hx\n\nHistory - Left breast cancer\n\n\nPath report.final diagnosis\n\n1. Breast, left, superior anterior margin, re-excision:     Benign mammary parenchyma with fat necrosis and foreign body-type giant cell       reaction, compatible with prior procedural site.     No evidence of residual invasive carcinoma or carcinoma in-situ.     No evidence of atypical proliferative breast disease. 2. Breast, left, inferior anterior margin, re-excision:     Benign mammary parenchyma with fat necrosis and foreign body-type giant cell       reaction, compatible with prior procedural site.     No evidence of residual invasive carcinoma or carcinoma in-situ.     No evidence of atypical proliferative breast disease.     Background mammary parenchyma with fibrocystic changes and focal       dystrophic calcifications. 3. Breast, left, medial anterior margin, re-excision:     Benign mammary parenchyma with fat necrosis and foreign body-type giant cell       reaction, compatible with prior procedural site.     No evidence of residual invasive carcinoma or carcinoma in-situ.     No evidence of atypical proliferative breast disease.\n\n\nPath report.microscopic examination\n\nMicroscopic examination is performed.\n\n\nPath report.site of origin\n\n1. Left breast superior anterior margin, long lateral/short superior 2. Left breast inferior anterior margin, long lateral/short superior 3. Medial anterior margin, long lateral/short superior (perm)\n\n\nPath report.comments\n\nComments - This case was reviewed in conjunction with the prior pathology (see 17-21-7973). There is no evidence of residual invasive mammary carcinoma, or associated ductal carcinoma in-situ.\n\n\n"
}